Michael Lauw

Michael Lauw has a wealth of experience in the pharmaceutical industry, with a focus on clinical operations and study management. Michael currently holds the role of Vice President, Development Operations at Surrozen since December 2020. Prior to that, they worked at BioMarin Pharmaceutical Inc. as the Global Medical Affairs, Sr. Director, Study Management from August 2018 to December 2020. Michael also served as the Director of Clinical Operations at Heron Therapeutics, Inc. from September 2016 to August 2018, and as the Associate Director of Clinical Operations at Receptos, Inc. from April 2014 to September 2016. Before that, they held various roles at Ardea Biosciences, ICON plc, and Quintiles, gaining experience in project management and clinical research.

Michael Lauw attended UC San Diego from 1989 to 2003, although no specific degree or field of study was mentioned. Michael then went on to pursue a Master's degree at San Diego State University from 2003 to 2005, specializing in Clinical/Medical Concentration.